54370-01-3 Usage
Appearance
White to off-white solid describes the physical form and color of the compound, which may vary slightly in shade.
Solubility
Insoluble in water, soluble in organic solvents refers to the compound's ability (or inability) to dissolve in different types of solvents, which can impact its applications and handling.
Uses
Intermediate in the synthesis of pharmaceuticals and agrochemicals indicates the compound's role as a precursor or building block in the production of various drugs and chemicals used in agriculture.
Reactivity
Possesses both bromine and chlorine atoms highlights the presence of these reactive halogens in the compound, which can participate in various chemical reactions and make it a versatile building block for creating other organic compounds.
Aromatic structure
A valuable compound for the development of new drugs and chemical products refers to the compound's aromatic nature, which can contribute to its stability and potential applications in medicinal chemistry and other fields.
Safety
Handle with care and follow proper safety protocols due to potential reactivity and toxicity emphasizes the importance of taking necessary precautions when working with this compound to minimize risks associated with its potential hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 54370-01-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,3,7 and 0 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 54370-01:
(7*5)+(6*4)+(5*3)+(4*7)+(3*0)+(2*0)+(1*1)=103
103 % 10 = 3
So 54370-01-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H10BrClO2/c1-12-8-3-6(5-11)7(10)4-9(8)13-2/h3-4H,5H2,1-2H3
54370-01-3Relevant articles and documents
NOVEL 6,7-DIHYDROPYRIDO[2,1-A]PHTHALAZIN-2-ONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
-
Page/Page column 21, (2017/02/24)
The invention provides novel compounds having the general formula: wherein R1 to R6 are as described herein, compositions including the compounds and methods of using the compounds.
2,3-DIHYDRO-1H-ISOINDOL-1-IMINE DERIVATIVES USEFUL AS THROMBIN PAR-1 RECEPTOR ANTAGONIST
-
Page/Page column 26, (2011/05/08)
The present invention is directed to novel 2,3-dihydro-1H-isoindol-1-imine derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the thrombin PAR-1 receptor antagonists.
TRISUBSTITUTED AMINE COMPOUNDS AS INHIBITORS OF -CHOLESTERYL ESTER TRANSFER PROTEIN CETP
-
Page/Page column 208-209, (2008/06/13)
The present invention relates to a compound of the general formula (1): (1)wherein, Y is a methylene group, and the like; A is an optionally substituted heterocyclic group, and the like; B is an optionally substituted phenyl group, and the like; R1 is an optionally substituted alkyl group, and the like; and R2 is an optionally substituted amino group, and the like; or a pharmaceutically acceptable derivative thereof, which has an inhibitory activity against cholesteryl ester transfer protein (CETP), thereby being useful for prophylaxis and/or treatment of arteriosclerotic diseases, hyperlipemia or dyslipidemia, and the like.